Intratumoral heterogeneity of CD44v6 in rectal cancer

The expression of CD44v6 in colon: from normal to malignant

(2016) Alaa Afify et al.   Annals of Diagnostic Pathology

Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells

(2016) Lin Lv et al.   TUMOR BIOLOGY

CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis

(2014) Matilde Todaro et al.   Cell Stem Cell

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance

(2014) Jie Ni et al.   PROSTATE

Cancer heterogeneity: implications for targeted therapeutics

(2013) R Fisher et al.   BRITISH JOURNAL OF CANCER

Tumour heterogeneity in the clinic

(2013) Philippe L. Bedard et al.   NATURE

The causes and consequences of genetic heterogeneity in cancer evolution

(2013) Rebecca A. Burrell et al.   NATURE

CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer

(2013) SEIYA SAITO et al.   ONCOLOGY REPORTS

Osteopontin-Enhanced Hepatic Metastasis of Colorectal Cancer Cells

(2012) Jianjin Huang et al.   PLoS One

Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence

(2012) Suvi Tuulia Avoranta   WORLD JOURNAL OF GASTROENTEROLOGY

HGF-Promoted Motility in Primary Human Melanocytes Depends on CD44v6 Regulated via NF-kappa B, Egr-1, and C/EBP-beta

(2010) Sabine Damm et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer

(2009) Inti Zlobec et al.   HISTOPATHOLOGY

CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-talk That Supports Adhesion and Apoptosis Resistance

(2009) P. Klingbeil et al.   MOLECULAR CANCER RESEARCH

Prediction of Treatment Outcome by CD44v6 After Total Mesorectal Excision in Locally Advanced Rectal Cancer

(2008) Junjie Peng et al.   CANCER JOURNAL